Skip Navigation



ToxSci Advance Access published online on December 13, 2007

Toxicological Sciences, doi:10.1093/toxsci/kfm301
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
104/2/235    most recent
kfm301v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by LoPachin, R. M.
Right arrow Articles by Gavin, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LoPachin, R. M.
Right arrow Articles by Gavin, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

MOLECULAR MECHANISMS OF THE CONJUGATED {alpha},β–UNSATURATED CARBONYL DERIVATIVES: RELEVANCE TO NEUROTOXICITY AND NEURODEGENERATIVE DISEASES

Richard M. LoPachin*, David S. Barber{dagger} and Terrence Gavin{Delta}

* Department of Anesthesiology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx NY 10467-2490 {dagger} Center for Environmental and Human Toxicology, University of Florida, Gainesville, FL 32611-0885 {Delta} Department of Chemistry, Iona College, New Rochelle, NY

Send Correspondence to: Richard M. LoPachin, Ph.D., Montefiore Medical Center, Moses Research Tower – 7, 111 E. 210th St. , Bronx, NY 10467-2490, (718) 920-5054 (phone), (718) 515-4903 (fax), lopachin{at}aecom.yu.edu. (e-mail)

Received October 3, 2007; revision received December 4, 2007; accepted December 4, 2007


   Abstract

Conjugated {alpha},β-unsaturated carbonyl derivatives such acrylamide (ACR), acrolein and 4-hydroxy-2-nonenal (HNE) are members of a large class of chemicals known as the type-2 alkenes. Human exposure through diet, occupation and pollution is pervasive and has been linked to toxicity in most major organs. Evidence suggests that these soft electrophiles produce toxicity by a common mechanism involving the formation of Michael-type adducts with nucleophilic sulfhydryl groups. In this commentary, the adduct chemistry of the {alpha},β-unsaturated carbonyls and possible protein targets will be reviewed. We also consider how differences in electrophilic reactivity among the type-2 alkenes impact corresponding toxicokinetics and toxicological expression. Whereas these concepts have mechanistic implications for the general toxicity of type-2 alkenes, this commentary will focus on the ability of these chemicals to produce presynaptic damage via protein adduct formation. Given the ubiquitous environmental presence of the conjugated alkenes, discussions of molecular mechanisms and possible neurotoxicological risks could be important. Understanding the neurotoxicodynamic of the type-2 alkenes might also provide mechanistic insight into neurodegenerative conditions where neuronal oxidative stress and presynaptic dysfunction are presumed initiating events. This is particularly germane to a recent proposal that lipid peroxidation and the subsequent liberation of acrolein and HNE in oxidatively stressed neurons mediate synaptotoxicity in brains of Alzheimer's disease patients. This endogenous neuropathogenic process could be accelerated by environmental type-2 alkene exposure since common nerve terminal proteins are targeted by {alpha},β-unsaturated carbonyl derivatives. Thus, the protein adduct chemistry of the conjugated type-2 alkenes offers a mechanistic explanation for the environmental toxicity induced by these chemicals and might provide insight into the pathogenesis of certain human neurodegenerative diseases.

Key Words: acrylamide; acrolein; Alzheimer's disease; 4-hydroxy-2-nonenal; synaptotoxicity; neurodegeneration.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
D. Tshala-Katumbay, V. Monterroso, R. Kayton, M. Lasarev, M. Sabri, and P. Spencer
Probing Mechanisms of Axonopathy. Part II: Protein Targets of 2,5-Hexanedione, the Neurotoxic Metabolite of the Aliphatic Solvent n-Hexane
Toxicol. Sci., February 1, 2009; 107(2): 482 - 489.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. M. LoPachin, B. C. Geohagen, and T. Gavin
Synaptosomal Toxicity and Nucleophilic Targets of 4-Hydroxy-2-Nonenal
Toxicol. Sci., January 1, 2009; 107(1): 171 - 181.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.